Dhivy

Active Ingredient(s): Carbidopa + Levodopa
FDA Approved: * November 12, 2021
Pharm Company: * RIVERSIDE PHARMA CORP
Category: Parkinsons

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Dhivy Overview

Carbidopa/levodopa, also known as levocarb and co-careldopa, is the combination of the two medications carbidopa and levodopa.[1] It is primarily used to manage the symptoms of Parkinson's disease, but it does not slow down the disease or stop it from getting worse.[1] It is taken by mouth.[1] It can take two to three weeks of treatment before benefits are seen.[2] Each dose then begins working in about ten minutes to two hours w...

Read more Dhivy Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Carbidopa/levodopa

Recent Dhivy Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Carbidopa + Levodopa
  • Capsule, Extended Release: 23.75mg + 95mg, 36.25mg + 145mg, 48.75mg + 195mg, 61.25mg + 245mg
  • Suspension: 4.63mg + 20mg, 4.63mg/ml + 20mg/ml
  • Tablet: 10mg + 100mg, 25mg + 100mg, 25mg + 250mg, 50mg + 200mg
  • Tablet, Extended Release: 25mg + 100mg, 50mg + 200mg
  • Tablet, For Suspension: 10mg + 100mg, 25mg + 100mg, 25mg + 250mg
  • Tablet, Orally Disintegrated: 10mg + 100mg, 25mg + 100mg, 25mg + 250mg
  • Tablet, Orally Disintegrating: 10mg + 100mg, 25mg + 100mg, 25mg + 250mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (16 results)